Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders

View ORCID ProfileJonathan Gilley, Oscar Jackson, Menelaos Pipis, Mehrdad A. Estiar, Ammar Al-Chalabi, Matt C. Danzi, Kristel R. van Eijk, View ORCID ProfileStephen A. Goutman, Matthew B. Harms, View ORCID ProfileHenry Houlden, Alfredo Iacoangeli, Julia Kaye, Leandro Lima, Queen Square Genomics, John Ravits, Guy A. Rouleau, Rebecca Schüle, Jishu Xu, Stephan Züchner, View ORCID ProfileJohnathan Cooper-Knock, Ziv Gan-Or, Mary M. Reilly, Michael P. Coleman
doi: https://doi.org/10.1101/2021.06.17.21258268
Jonathan Gilley
1John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan Gilley
  • For correspondence: mc469@cam.ac.uk jg792@cam.ac.uk
Oscar Jackson
1John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Menelaos Pipis
2Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, WC1N 3BG, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehrdad A. Estiar
3Department of Human Genetics, McGill University, Montreal, H3A 1A1, Canada
4The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, H3A 2B4, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ammar Al-Chalabi
5Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
6Department of Neurology, King’s College Hospital, King’s College London, London, SE5 9RS, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matt C. Danzi
7Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristel R. van Eijk
8Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, 3584 CG, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen A. Goutman
9Department of Neurology, University of Michigan, Ann Arbor, MI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephen A. Goutman
Matthew B. Harms
10Institute for Genomic Medicine, Columbia University, New York, NY100332, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry Houlden
2Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, WC1N 3BG, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Henry Houlden
Alfredo Iacoangeli
5Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
11Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, SE5 8AF, London, UK
12National Institute for Health Research Biomedical Research Centre and Dementia Unit at South London and Maudsley NHS Foundation Trust and King’s College London, London, SE5 8AF, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Kaye
13Finkbeiner lab, Center for Systems and Therapeutics, Bioinformatics Core, Institute of Data Science and Biotechnology, Gladstone Institutes, 1650 Owens Street, San Francisco, CA 94158, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leandro Lima
13Finkbeiner lab, Center for Systems and Therapeutics, Bioinformatics Core, Institute of Data Science and Biotechnology, Gladstone Institutes, 1650 Owens Street, San Francisco, CA 94158, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
2Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, WC1N 3BG, UK
John Ravits
14Department of Neurosciences, University of California, San Diego, La Jolla, CA92093, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guy A. Rouleau
3Department of Human Genetics, McGill University, Montreal, H3A 1A1, Canada
4The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, H3A 2B4, Canada
15Department of Neurology and Neurosurgery, McGill University, Montreal, H3A 1A1, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca Schüle
16Center for Neurology and Hertie Institute für Clinical Brain Research, University of Tübingen, German Center for Neurodegenerative Diseases, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jishu Xu
16Center for Neurology and Hertie Institute für Clinical Brain Research, University of Tübingen, German Center for Neurodegenerative Diseases, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan Züchner
7Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johnathan Cooper-Knock
17Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, S10 2HQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Johnathan Cooper-Knock
Ziv Gan-Or
3Department of Human Genetics, McGill University, Montreal, H3A 1A1, Canada
4The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, H3A 2B4, Canada
15Department of Neurology and Neurosurgery, McGill University, Montreal, H3A 1A1, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary M. Reilly
2Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, WC1N 3BG, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael P. Coleman
1John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mc469@cam.ac.uk jg792@cam.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

SARM1, a protein with critical NADase activity, is a central executioner in a conserved programme of axon degeneration. We report seven rare missense or in-frame microdeletion human SARM1 variant alleles in patients with amyotrophic lateral sclerosis (ALS) or other motor nerve disorders that alter the SARM1 auto-inhibitory ARM domain and constitutively hyperactivate SARM1 NADase activity. The constitutive NADase activity of these seven variants is similar to that of SARM1 lacking the entire ARM domain and greatly exceeds the activity of wild-type SARM1, even in the presence of nicotinamide mononucleotide (NMN), its physiological activator. This rise in constitutive activity alone is enough to promote neuronal degeneration in response to otherwise non-harmful, mild stress. Importantly, these strong gain-of-function alleles are completely patient-specific in the cohorts studied and show a highly significant association with disease at the single gene level. These findings of disease-associated coding variants that alter SARM1 function build on previously reported genome-wide significant association with ALS for a neighbouring, more common SARM1 intragenic single nucleotide polymorphism (SNP) to support a contributory role of SARM1 in these disorders. A broad phenotypic heterogeneity and variable age-of-onset of disease among patients with these alleles also raises intriguing questions about the pathogenic mechanism of hyperactive SARM1 variants.

Competing Interest Statement

Funding of academic projects from AstraZeneca and Michael Coleman is a consultant for Nura Bio.

Funding Statement

This work was supported by a grant from the Robert Packard Center for ALS Research at Johns Hopkins (to M.P.C, also supporting J.G.) and in part by data provided by the Answer ALS Consortium, also administered by the Robert Packard Center. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of The Johns Hopkins University or any grantor proving funds to its Robert Packard Center for ALS Research. Parts of this work were also supported by UK Biotechnology and Biological Sciences Research Council (BBSRC) / AstraZeneca Industrial Partnership award BB/S009582/1 (to M.P.C, also supporting J.G., O.J.) and Wellcome Trust Collaborative award 220906/Z/20/Z (to M.P.C and M.M.R, also supporting J.G., O.J., M.P.). Additional support was provided by UK Medical Research Council (MRC) awards MR/L501529/1 and MR/R024804/1 and the UK Economic and Social Research Council (ESRC) award ES/L008238/1 under the aegis of the EU Joint Programme, Neurodegenerative Disease Research (JPND) (www.jpnd.eu) (to A.A-C.), the Motor Neurone Disease (MND) Association and the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London (A.A-C., A.I.), National Institute of Neurological Diseases and Stroke (NINDS) and office of Rare Diseases awards U54NS065712 (to M.M.R., also supporting M.P.), and 5R01NS072248-10 and 5R01NS105755-03 (to S.Z., also supporting M.C.D.), National Institute of Environmental Health Sciences (NIEHS) award K23ES027221 (to S.A.G.), and Wellcome Trust award 216596/Z/19/Z (to J.C.K.). Samples used in this research were in part obtained from the UK National DNA Bank for MND Research, funded by the MND Association and the Wellcome Trust. Sample management was undertaken by Biobanking Solutions funded by the MRC at the Centre for Integrated Genomic Medical Research, University of Manchester. Whole-genome sequencing of the Lothian Birth Cohorts was funded by the Biotechnology and Biological Sciences Research Council.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This is a retrospective study using anonymised data so specific consent was not obtained by the authors, but consent was obtained at each site that contributed patient information to this study in accordance with their local Institutional Review Boards (IRBs). Patient information for the Answer ALS project dataset was already publicly available at the initiation of this study. Non-public datasets were covered by the following IRBs: the Comité de ética de la Investigación del Hospital Carlos III, Madrid, Spain; the University Medical Center Utrecht Medical Ethics Committee, Utrecht, The Netherlands; the Committee for the Protection of Human Subjects in Research of the University of Massachusetts Medical School, Worcester, MA, USA; and the Trent University Medical Ethics Committee, UK for Project MinE patients; the Benaroya Research Institute IRB, Seattle, WA, USA; the University of California San Diego IRB, San Diego, CA, USA; and the University of Miami IRB committee (20070282 / MODCR00002569), Miami, FL, USA for GENESIS patients; the London - Queen Square Research Ethics Committee (study. no. 09/H0716/61), UK for the UCL cohort patient; and the University of Michigan IRB (HUM00116765), Ann Arbor, MI, USA for the unattributed patient. Non-public datasets can be obtained on request.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵† Lead contact

Data Availability

All relevant data is presented in the manuscript and/or links or citations are provided to the databases used. Project MinE data freeze 1 allele frequency data and clinical datasets for Answer ALS patients presented in this study are freely searchable/available (see links below). If additional information relating to other allele frequencies and/or clinical data is required then the corresponding authors would be able to facilitate contact with the appropriate database managers and/or clinicians.

http://databrowser.projectmine.com/

https://dataportal.answerals.org/home

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders
Jonathan Gilley, Oscar Jackson, Menelaos Pipis, Mehrdad A. Estiar, Ammar Al-Chalabi, Matt C. Danzi, Kristel R. van Eijk, Stephen A. Goutman, Matthew B. Harms, Henry Houlden, Alfredo Iacoangeli, Julia Kaye, Leandro Lima, Queen Square Genomics, John Ravits, Guy A. Rouleau, Rebecca Schüle, Jishu Xu, Stephan Züchner, Johnathan Cooper-Knock, Ziv Gan-Or, Mary M. Reilly, Michael P. Coleman
medRxiv 2021.06.17.21258268; doi: https://doi.org/10.1101/2021.06.17.21258268
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders
Jonathan Gilley, Oscar Jackson, Menelaos Pipis, Mehrdad A. Estiar, Ammar Al-Chalabi, Matt C. Danzi, Kristel R. van Eijk, Stephen A. Goutman, Matthew B. Harms, Henry Houlden, Alfredo Iacoangeli, Julia Kaye, Leandro Lima, Queen Square Genomics, John Ravits, Guy A. Rouleau, Rebecca Schüle, Jishu Xu, Stephan Züchner, Johnathan Cooper-Knock, Ziv Gan-Or, Mary M. Reilly, Michael P. Coleman
medRxiv 2021.06.17.21258268; doi: https://doi.org/10.1101/2021.06.17.21258268

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (241)
  • Allergy and Immunology (521)
  • Anesthesia (125)
  • Cardiovascular Medicine (1425)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (585)
  • Epidemiology (10307)
  • Forensic Medicine (6)
  • Gastroenterology (528)
  • Genetic and Genomic Medicine (2637)
  • Geriatric Medicine (254)
  • Health Economics (497)
  • Health Informatics (1740)
  • Health Policy (790)
  • Health Systems and Quality Improvement (676)
  • Hematology (268)
  • HIV/AIDS (568)
  • Infectious Diseases (except HIV/AIDS) (12103)
  • Intensive Care and Critical Care Medicine (649)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2466)
  • Nursing (145)
  • Nutrition (379)
  • Obstetrics and Gynecology (493)
  • Occupational and Environmental Health (568)
  • Oncology (1327)
  • Ophthalmology (403)
  • Orthopedics (147)
  • Otolaryngology (238)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (343)
  • Pediatrics (784)
  • Pharmacology and Therapeutics (330)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2405)
  • Public and Global Health (5018)
  • Radiology and Imaging (895)
  • Rehabilitation Medicine and Physical Therapy (530)
  • Respiratory Medicine (682)
  • Rheumatology (309)
  • Sexual and Reproductive Health (256)
  • Sports Medicine (246)
  • Surgery (298)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)